KATELYN SPADALIK: Open Payments
NPI 1396210050 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,935 in 150 payments from 16 companies in 2025. Trend: 2023 $2,412 · 2024 $2,471 · 2025 $2,935
Food & beverage: $2,930Education: $5
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 25 | $657 |
| Galderma Laboratories, L.P. | 30 | $367 |
| Novartis Pharmaceuticals Corporation | 15 | $294 |
| ABBVIE INC. | 12 | $292 |
| Janssen Biotech, Inc. | 14 | $284 |
| GENZYME CORPORATION | 4 | $220 |
| LEO Pharma Inc. | 15 | $203 |
| Incyte Corporation | 9 | $179 |
| Regeneron Healthcare Solutions, Inc. | 8 | $142 |
| Amgen Inc. | 3 | $72 |
Products named: Zoryve, DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, AKLIEF, OPZELURA, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
